ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0121

Rheumatoid Arthritis Care Experiences of Black People Living in Canada: A Qualitative Study to Inform Treatment Guidelines

Megan Thomas1, Cheryl Barnabe2, Tessa Kleissen2, Diane Lacaille3, Glen Hazlewood2, Nejat Hassen4, Richard Henry5, Kelly English6, Michael Kuluva7, Aurore Fifi-Mah2 and Nicole Johnson2, 1University of British Columbia, Vancouver, BC, Canada, 2University of Calgary, Calgary, AB, Canada, 3Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 4University of British Columbia, Arthritis Research Canada, RICHMOND, BC, Canada, 5McGill University, Montréal, QC, Canada, 6Arthritis Patient Advisory Board of Arthritis Research Canada, Vancouver, BC, Canada, 7Creaky Joints, Vancouver, BC, Canada

Meeting: ACR Convergence 2022

Keywords: Clinical practice guidelines, Health Services Research, race/ethnicity, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Healthcare Disparities in Rheumatology Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Guidelines may unintentionally introduce inequities in care through recommendations that do not reflect the realities of healthcare access and quality for persons who are marginalized in society. To inform future rheumatology guidelines that uphold equity for Black people living in Canada, we conducted semi-structured interviews to understand experiences related to rheumatoid arthritis (RA) care and suggested service-level strategies for reducing and mitigating inequities.

Methods: Interviews were conducted with individuals who identify as Black, live in Canada, and have a diagnosis of RA; they were recruited using purposive and snowball sampling. Three overarching questions were explored with participants: i) population factors relevant to RA care; ii) initial and ongoing access to healthcare services; and iii) medication access and treatment strategy. Interviews were conducted via Zoom and audio-recordings were transcribed. A thematic analysis using the Braun and Clarke method with a deductive coding approach, using Critical Race Theory and a racial equity lens to guide analysis.

Results: Participants (n=6; 4 females and 2 males) expressed how their racial identity as a Black person contributed to their understanding of RA and their preferences for treatment and outcome goals. They shared how healthcare access is influenced by financial resource limitations and racism, exclusion and discrimination, but also by cultural norms in seeking healthcare and lack of knowledge about RA within the Black community. These limitations were exacerbated by intersectionality between race, sex, and gender, particularly when it came to stereotypes around pain tolerance expectations, and experiences of implicit bias. Participants stated that they experience health system fragmentation and are not supported in seeking ancillary supports. Financial barriers to medication access are encountered, with decision making about treatment influenced by the legacy of oppression and medical experimentation on Black people, and the predominance of biomedical approaches emphasized by healthcare providers. Participants indicated that RA care needs to shift to include and promote holistic and cultural approaches, provided in safe and trauma-informed care environments, and with flexibility in service models to accommodate persons facing financial barriers. Partnerships between arthritis care services and Black community organizations would increase community awareness and knowledge about arthritis, provide mechanisms of support for patients within their community, and serve to empower patients.

Conclusion: Arthritis care providers need to consider unique experiences of arthritis care based on race and ethnicity. Identified barriers to care must be addressed, while high quality, culturally relevant, and safe care must be facilitated through recommendations in treatment guidelines to achieve optimal arthritis outcomes of Black patients with RA in Canada.


Disclosures: M. Thomas, None; C. Barnabe, Janssen, Fresenius Kabi, Celltrion Healthcare, Pfizer; T. Kleissen, None; D. Lacaille, None; G. Hazlewood, None; N. Hassen, None; R. Henry, None; K. English, None; M. Kuluva, None; A. Fifi-Mah, Eli lilly, Pfizer, Janssen, BMS; N. Johnson, None.

To cite this abstract in AMA style:

Thomas M, Barnabe C, Kleissen T, Lacaille D, Hazlewood G, Hassen N, Henry R, English K, Kuluva M, Fifi-Mah A, Johnson N. Rheumatoid Arthritis Care Experiences of Black People Living in Canada: A Qualitative Study to Inform Treatment Guidelines [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/rheumatoid-arthritis-care-experiences-of-black-people-living-in-canada-a-qualitative-study-to-inform-treatment-guidelines/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-care-experiences-of-black-people-living-in-canada-a-qualitative-study-to-inform-treatment-guidelines/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology